EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EYPT EyePoint

交易中 11-21 13:48:36 EST

8.54

-0.41

-4.63%

最高9.07	最低8.46	成交量99.13万
今开9.00	昨收8.96	日振幅6.76%
总市值5.99亿	流通市值4.31亿	总股本7,016万
成交额876.22万	换手率1.96%	流通股本5,049万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":8.54,"timestamp":1732214915680,"preClose":8.955,"halted":0,"volume":991277,"delay":0,"floatShares":50492000,"shares":70160121,"eps":-2.042982,"marketStatus":"交易中","marketStatusCode":2,"change":-0.415,"latestTime":"11-21 13:48:36 EST","open":9,"high":9.065,"low":8.46,"amount":8762224.52441,"amplitude":0.06756,"askPrice":8.56,"askSize":42,"bidPrice":8.53,"bidSize":239,"shortable":3,"etf":0,"ttmEps":-2.042982,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732222800000},"adr":0,"adjPreClose":8.955,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.9996,"preClose":8.955,"latestTime":"08:57 EST","volume":2464,"amount":22144.152800000003,"timestamp":1732197421683},"postHourTrading":{"tag":"盘后","latestPrice":8.9,"preClose":8.955,"latestTime":"19:59 EST","volume":182876,"amount":1637648.2,"timestamp":1732150740898},"volumeRatio":1.352341,"impliedVol":0.1468,"impliedVolPercentile":0.0119},"requestUrl":"/m/hq/s/EYPT","defaultTab":"news","newsList":[{"id":"2485616140","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485616140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485616140?lang=zh_cn&edition=full","pubTime":"2024-11-21 01:13","pubTimestamp":1732122822,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日01时13分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.10%。截至发稿，该股报8.74美元/股，成交量75.8644万股，换手率1.11%，振幅4.07%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Forte Biosciences, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1539.14%、1225.41%、755.10%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112101134298e43c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112101134298e43c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","EYPT","LU0889565916.HKD","BK4588","BK4585","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"2484929200","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.13%报9.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929200?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:35","pubTimestamp":1732030518,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时35分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.13%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃，换手率分别为708.04%、112.07%、102.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为81.67%、62.18%、52.14%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233519971a777d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119233519971a777d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4585","BK4588","LU0889565916.HKD","EYPT","BK4007","LU0109394709.USD"],"gpt_icon":0},{"id":"2484131607","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速下跌5.02%报8.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484131607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484131607?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:45","pubTimestamp":1731955518,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时45分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.02%。截至发稿，该股报8.71美元/股，成交量54.982万股，换手率0.81%，振幅6.05%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1266.62%、1207.89%、567.31%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024518971a7412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024518971a7412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","EYPT","BK4007","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2483851333","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速下跌5.04%报10.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483851333?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:34","pubTimestamp":1731526458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时34分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.04%。截至发稿，该股报10.55美元/股，成交量28.9779万股，换手率0.42%，振幅7.25%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Calidi Biotherapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为582.46%、551.50%、161.05%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为139.00%、86.83%、73.71%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403341898e42723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403341898e42723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","EYPT"],"gpt_icon":0},{"id":"2482773144","title":"美国研究综述-Cable One、Neurogene、Topbuild","url":"https://stock-news.laohu8.com/highlight/detail?id=2482773144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482773144?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:43","pubTimestamp":1731404607,"startTime":"0","endTime":"0","summary":"    路透11月12日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cable One、Neurogene 和 Topbuild。要闻 * Cable One Inc   ：摩根大通将目标价从480美元下调至470美元 * Hudson Pacific Properties Inc   ：杰富瑞将目标价从 \"买入 \"下调至 \"持有  * Neurogene Inc   ：Leerink Partners将目标价从45美元上调至72美元 * Rapt Therapeutics Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU","EOG","LU1003077747.HKD","DOCS","GPMT","JLL","BK4123","EYPT","ARMK","DAL","ARDT","ARCB","HPP","CMTG","AIZ","CDE","CTVA","LU0256331488.USD","BLD","BMY","LU0648001328.SGD","LU2242652126.USD","AL","BK4101","CABO","BAX","APD","FTRE","ABBV","AEO","ALB","LU0211328371.USD","HMN","IE00BBT3K403.USD","BILL","BLMN","DB","FTNT","DKNG","ATLC","ADSK","CACI","AIG","IMXI","AGL","CCL","LU0070302665.USD","AFG"],"gpt_icon":1},{"id":"1136530151","title":"异动解读 | EyePoint Pharmaceuticals股价大涨,市场关注其前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1136530151","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136530151?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:24","pubTimestamp":1731342268,"startTime":"0","endTime":"0","summary":"11月11日,EyePoint Pharmaceuticals股票出现大涨行情,盘中一度上涨5.07%,股价报12.22美元。作为一家专注于眼科药物研发的生物科技公司,EyePoint的股价走势备受市场关注。尽管目前依然处于亏损状态,但其眼科药物产品线前景广阔。值得注意的是,所有12家分析机构均给予EyePoint\"买入\"评级,反映出市场对该公司的长期增长前景充满信心。随着新药研发进展,若临床数据获得积极进展,有望进一步提振公司股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | EyePoint Pharmaceuticals股价大涨,市场关注其前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EYPT"],"gpt_icon":0},{"id":"2482673238","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482673238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482673238?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:14","pubTimestamp":1731341669,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时14分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.07%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Cero Therapeutics Holdings, Inc.、Lakeshore Biopharma Co., Ltd、Aligos Therapeutics, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为602.85%、478.37%、170.05%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为123.43%、72.42%、61.39%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001429abb697a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001429abb697a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","EYPT"],"gpt_icon":0},{"id":"2481781134","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481781134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481781134?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:19","pubTimestamp":1731003542,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时19分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.13%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为928.14%、470.59%、119.16%，振幅较大的相关个股有Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为126.21%、98.82%、72.18%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108021902971a52a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108021902971a52a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","EYPT","BK4007","LU0109394709.USD","LU0320765992.SGD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2481398322","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481398322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481398322?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:42","pubTimestamp":1730904135,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时42分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.08%。截至发稿，该股报12.20美元/股，成交量5.2185万股，换手率0.08%，振幅2.93%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1132.44%、135.84%、61.37%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Theravance Biopharma, Inc.、Sutro Biopharma, Inc.，振幅分别为107.49%、104.84%、104.17%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224216aba6b6e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224216aba6b6e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4007","EYPT","LU0889565916.HKD","BK4588","BK4585"],"gpt_icon":0},{"id":"2481060768","title":"EyePoint Pharmaceuticals Inc    预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481060768","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481060768?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:10","pubTimestamp":1730902204,"startTime":"0","endTime":"0","summary":"   * EyePoint Pharmaceuticals Inc    预计将在11月8日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，11位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收预计将从去年同期的1520万美元下降31.4%，至1042.3万美元。* LSEG分析师对EyePoint Pharmaceuticals Inc的平均预期是每股亏损55美分。* 华尔街对 EyePoint Pharmaceuticals Inc 的 12 个月目标价中位数为 32.50 美元，高于其最新收盘价 11.61 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EyePoint Pharmaceuticals Inc    预计每股亏损 55 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2480587394","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587394?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:39","pubTimestamp":1730731141,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时39分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.06%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为243.30%、147.63%、48.64%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为29.83%、22.67%、21.13%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422390198e40499&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422390198e40499&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0320765992.SGD","BK4585","LU0889565916.HKD","BK4007","EYPT","LU0109394709.USD"],"gpt_icon":0},{"id":"2480063982","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速上涨5.37%报12.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480063982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480063982?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:20","pubTimestamp":1730402446,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时20分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.37%。截至发稿，该股报12.08美元/股，成交量95.8575万股，换手率1.79%，振幅9.25%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.24%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Quince Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为275.82%、244.27%、199.38%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Promis Neurosciences Inc.、Vaccinex, Inc.，振幅分别为80.77%、51.56%、47.30%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101032046971a39ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101032046971a39ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","EYPT","BK4007","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"1171726107","title":"异动解读 | EyePoint因发行新股而遭遇股价重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1171726107","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171726107?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:54","pubTimestamp":1730253265,"startTime":"0","endTime":"0","summary":"EyePoint制药公司(EYPT)在10月29日盘中出现大幅下跌,股价一度大跌8.09%,引发了市场的广泛关注。\n\n导致该公司股价下跌的主要原因是,EyePoint宣布公开发行价值1亿美元的新股。此举将增加公司股票供应量,导致现有股东权益遭到进一步稀释,因此引发了投资者的担忧情绪。消息公布后,股价在盘后一度下挫8.5%,最低跌至11.09美元。\n\n不过,EyePoint表示将利用此次发行所得资金继续推进其糖尿病黄斑水肿药物Duravyu的开发工作,并支持其他早期管线产品的研发。但这一利好消息似乎难以完全抵消新股发行导致股权稀释对股价的冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EYPT"],"gpt_icon":0},{"id":"1167697008","title":"异动解读 | EyePoint制药公司发行新股致股价大挫5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167697008","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167697008?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:44","pubTimestamp":1730220269,"startTime":"0","endTime":"0","summary":"EyePoint(EYPT)制药公司股价在10月29日盘中大跌5.03%,引发了市场的广泛关注。导致该公司股价下跌的主要原因是,EyePoint宣布公开发行价值1亿美元的新股。\n\n新股的发行将增加公司股票供应量,导致现有股东权益遭到进一步稀释,因此引发了投资者的担忧情绪。股价在盘后一度下挫8.5%,最低跌至11.09美元。\n\n不过,EyePoint表示将利用此次发行所得资金继续推进其糖尿病黄斑水肿药物Duravyu的开发工作,并支持其他早期管线产品的研发。但这一利好消息似乎并未抵消新股发行导致股权稀释对股价的冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EYPT"],"gpt_icon":0},{"id":"2479362072","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.12%报11.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479362072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479362072?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:43","pubTimestamp":1730220222,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时43分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.12%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1330.10%、1189.44%、330.41%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030004342ab7f9753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030004342ab7f9753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","EYPT","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"1193387727","title":"异动解读 | EyePoint公司发行新股导致股价大跌7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193387727","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193387727?lang=zh_cn&edition=full","pubTime":"2024-10-29 16:16","pubTimestamp":1730189778,"startTime":"0","endTime":"0","summary":"EyePoint制药公司(EYPT)股价在10月29日盘前大跌7.34%,引发了市场的广泛关注。\n\n导致该公司股价下跌的主要原因是,公司宣布公开发行价值1亿美元的新股。这一举措将增加公司股票供应量,导致现有股东的权益遭到进一步稀释,因此引发了投资者的担忧情绪。\n\n根据公告,此次发行由摩根大通、花旗集团和古根海姆证券三家公司联合担任簿记管理人。股价在盘后一度进一步下跌8.5%至11.09美元。不过,EyePoint表示将利用此次发行所得资金继续推进其糖尿病黄斑水肿药物Duravyu的开发工作,并支持其他早期管线产品的研发。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EYPT"],"gpt_icon":0},{"id":"1170077564","title":"异动解读 | EyePoint 宣布发行新股后股价大幅下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1170077564","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170077564?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:44","pubTimestamp":1730187874,"startTime":"0","endTime":"0","summary":"EyePoint制药公司10月28日夜盘大跌5.12%,引发市场广泛关注。消息显示,此前EyePoint宣布公开发行价值1亿美元的新股,这可能是导致股价下跌的主要原因。盘后股价一度下跌8.5%至11.09美元。不过,EyePoint的糖尿病黄斑水肿药物Duravyu在临床试验中取得积极进展,公司表示将利用此次发行所得资金继续推进该药物的开发工作,并支持早期管线产品的研发。但该利好消息似乎并未抵消股权稀释对股价的冲击。EyePoint目前市值约为6.49亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | EyePoint 宣布发行新股后股价大幅下挫","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EYPT"],"gpt_icon":0},{"id":"2479694774","title":"BUZZ-EyePoint 公布发行 1 亿美元股票后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2479694774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479694774?lang=zh_cn&edition=full","pubTime":"2024-10-29 06:22","pubTimestamp":1730154131,"startTime":"0","endTime":"0","summary":" (更新)    10月28日 - ** EyePoint Pharmaceuticals   盘后股价下跌8.5%至11.09美元** EYPT 宣布   公开发行价值 1 亿美元的股票     ** 摩根大通、花旗集团和古根海姆证券是此次发行的联合簿记管理人     ** EYPT 股票周一收盘上涨 27.6%，报 12.12 美元     ** 公司有 5350 万股流通股，市值达 6.486 亿美元--伦敦证券交易所数据** 当天早些时候，EYPT称其 药物Duravyu在糖尿病黄斑水肿的中期试验中显示，患者远距离观察物体的能力有所改善** EYPT计划利用所得资金推进Duravyu的开发，并支持其早期管线开发计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","EYPT","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2479343922","title":"BUZZ--美国股票走势-Monte Rosa、EyePoint Pharma、Shake Shack","url":"https://stock-news.laohu8.com/highlight/detail?id=2479343922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479343922?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:28","pubTimestamp":1730132923,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月28日 - 华尔街周一开盘走高，美国主要股指在经历了动荡的一周交易后有望收复部分失地，此前将有一系列大型公司发布财报，11月5日总统大选也将进入最后阶段。美东时间12:20，道琼斯工业平均指数  上涨0.68%，报42,402.47点。标普500指数  上涨0.45%，报5,834.04点；纳斯达克综合指数  上涨0.58%，报18,625.62点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca438d53490fb5e5880a84acba8fd54e","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","ON","NVDA","L","AMIX","XOM","HUT","CCL","REAL","RBLX","MANU","ABBV","GLUE","COP","PRCT","3NVD.UK","HE","SHAK","TQQQ","GEHC","RVNC","AZUL","MNQmain","2NVD.UK","GLW","CDW","MSFT","SQQQ","DDM","EVOK","DOG",".IXIC","CNC","QLD","SDOW","ADT","QID","AMZN",".DJI","AAPL","EYPT",".SPX"],"gpt_icon":1},{"id":"2478248147","title":"BUZZ-眼病药物试验数据良好，EyePoint 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2478248147","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478248147?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:11","pubTimestamp":1730124700,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月28日 - ** EyePoint Pharmaceuticals   股价上涨36.5%，达到12.96美元的五个月新高** 该公司称其药物Duravyu在糖尿病黄斑水肿的中期试验中显示，患者看清远处物体的能力有所改善(DME)** 糖尿病黄斑水肿是一种导致糖尿病患者视力模糊的眼部疾病。** 该公司预计将于 2025 年第一季度发布全面业绩报告** 包括本交易日的走势在内，EYPT股价今年累计下跌了50.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0889565916.HKD","BK4588","LU0109394709.USD","EYPT","BK4007","LU0320765992.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eyepointpharma.com","stockEarnings":[{"period":"1week","weight":-0.1678},{"period":"1month","weight":-0.1631},{"period":"3month","weight":-0.005},{"period":"6month","weight":-0.1976},{"period":"1year","weight":0.4632},{"period":"ytd","weight":-0.6125}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"EyePoint Pharmaceuticals Inc.于2008年3月成为特拉华州公司。其前身，pSivida有限公司于2000年12月在西澳大利亚注册成立一家澳大利亚公司。 pSivida开发微小，缓释，药物输送的产品。该公司用于药物输送的产品，依其设计，几个月或几年中都可控制和稳定输送药物速率。pSivida公司专注于利用其核心技术平台，Durasert和BioSilicon治疗眼睛后部的慢性疾病。 pSivida目前有三个认可的产品和两个主要正在开发的候选产品，这些产品代表了连续几代的Durasert技术平台。 pSivida公司开发的四分之三用于治疗视网膜疾病的缓释装置，目前已获得美国或欧洲联盟（欧盟）的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.578947,"avgChangeRate":0.064874},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000798},{"month":3,"riseRate":0.4,"avgChangeRate":0.006089},{"month":4,"riseRate":0.5,"avgChangeRate":0.150438},{"month":5,"riseRate":0.35,"avgChangeRate":-0.002292},{"month":6,"riseRate":0.3,"avgChangeRate":-0.036354},{"month":7,"riseRate":0.6,"avgChangeRate":0.044635},{"month":8,"riseRate":0.3,"avgChangeRate":-0.034851},{"month":9,"riseRate":0.35,"avgChangeRate":-0.003697},{"month":10,"riseRate":0.35,"avgChangeRate":-0.045956},{"month":11,"riseRate":0.45,"avgChangeRate":-0.058321},{"month":12,"riseRate":0.368421,"avgChangeRate":0.125153}],"exchange":"NASDAQ","name":"EyePoint","nameEN":"EyePoint"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"EyePoint,EYPT,EyePoint股票,EyePoint股票老虎,EyePoint股票老虎国际,EyePoint行情,EyePoint股票行情,EyePoint股价,EyePoint股市,EyePoint股票价格,EyePoint股票交易,EyePoint股票购买,EyePoint股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}